Related references
Note: Only part of the references are listed.Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea
Dana S. Clutter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies
Panayiotis D. Ziakas et al.
PLOS ONE (2013)
Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
Michelle M. Nerandzic et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clostridium difficile infection in HIV-seropositive individuals and transplant recipients
Paul J. Collini et al.
JOURNAL OF INFECTION (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Comparative Effectiveness of Clostridium difficile Treatments A Systematic Review
Dimitri M. Drekonja et al.
ANNALS OF INTERNAL MEDICINE (2011)
Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile
Farah Babakhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
Kathleen M. Mullane et al.
CLINICAL INFECTIOUS DISEASES (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease
Wafa N. Al-Nassir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Analysis of 30-day mortality for Clostridium difficile -: Associated disease in the ICU setting
Claire Kenneally et al.
CHEST (2007)
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
L Kyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
